Clinical trial
Observer Blinded, Randomized Trial to Evaluate Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP
NCT04033068 is registered in ClinicalTrials.gov with Themis Bioscience GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observer Blinded, Randomized Trial to Evaluate Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP
- Lead sponsor
- Themis Bioscience GmbH
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 2, 2019
- Completion date
- June 10, 2020
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.